ANRO Alto Neuroscience, Inc. Common Stock
$25,31
Fiyat · May 1, 2026
Temel veriler itibarıyla Mar 16, 2026
52 Haftlık Aralık
$2–$28
88% of range
Analist Derecelendirmesi
STRONG BUY
16 analysts
Fiyat Hedefi
$35
+39% upside
P/E (TTM)
-8.1
ROE
-46.1%
Net Kâr Marjı
—
ANRO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$25.30
Piyasa Değeri
$568M
P/E (TTM)
-8.1
EPS (TTM)
$-2.19
Gelir (TTM)
—
Temettü Verimi
—
ROE
-46.1%
D/E Borç/Özsermaye
0.1
52 Haftlık Aralık
$2 – $28
ANRO Hisse Senedi Fiyat Grafiği Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-2.19
2023-12-31
→
2025-12-31
Serbest Nakit Akışı
$-52M
2024-12-31
→
2025-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ANRO
Akran Ortalaması
P/E (TTM)
-8.1
42.1
P/B (F/D)
3.8
2.5
EV / EBITDA
-6.2
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-11.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ANRO
Akran Ortalaması
ROA
-34.9%
-22.8%
ROE
-46.1%
-48.2%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ANRO
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.1
47.0
Current Ratio (Cari Oran)
15.7
4.2
Quick Ratio (Cari Oran)
15.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ANRO
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ANRO
Akran Ortalaması
ANRO Analist Konsensüsü Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
16 analist
- Güçlü Al 7 43,8%
- Al 7 43,8%
- Tut 2 12,5%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
9 analist · 2026-05-01
Medyan
$35.00
Şimdi
$25.30
Düşük
$21.00
Yüksek
$50.00
Medyan hedef
$35.00
+38,3%
Ortalama hedef
$35.27
+39,4%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.04%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Aralık 2025 | $-0.58 | $-0.54 | -0.04% |
| 30 Eylül 2025 | $-0.52 | $-0.68 | 0.16% |
| 30 Haziran 2025 | $-0.65 | $-0.63 | -0.02% |
| 31 Mart 2025 | $-0.56 | $-0.62 | 0.06% |
Emsal Karşılaştırma Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| LBRX | $563M | -7.1 | — | — | -25.5% | — |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| SGP | — | — | — | — | 50.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| ETON | $457M | — | 104.9% | -5.8% | -18.4% | 53.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $46M | $47M | $30M | |
| SG&A Expense | $21M | $22M | $8M | |
| Operating Expenses | $66M | $69M | $38M | |
| Operating Income | $-66M | $-69M | $-38M | |
| Interest Income | $7M | $9M | $2M | |
| Other Non-op | $3M | $7M | $2M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-63M | $-61M | $-36M | |
| EPS (Basic) | $-2.19 | $-2.50 | $-9.73 | |
| EPS (Diluted) | $-2.19 | $-2.50 | $-9.73 | |
| Shares (Basic) | 28,852,000 | 24,602,000 | 3,731,000 | |
| Shares (Diluted) | 28,852,000 | 24,602,000 | 3,731,000 | |
| EBITDA | $-66M | $-68M | · |
Bilanço 20
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $176M | $168M | $83M | |
| Prepaid Expense | $1M | $1M | $3M | |
| Other Current Assets | · | $30.0K | $112.0K | |
| Current Assets | $178M | $169M | $85M | |
| PP&E (Net) | $2M | $3M | $1M | |
| Accum. Depreciation | $2M | $1M | $684.0K | |
| Total Assets | $185M | $178M | $87M | |
| Accounts Payable | $2M | $2M | $1M | |
| Accrued Liabilities | $9M | $8M | $5M | |
| Current Liabilities | $11M | $10M | $6M | |
| Capital Leases | $4M | $5M | $0 | |
| Total Liabilities | $34M | $26M | $17M | |
| Long-term Debt | $17M | $10M | $10M | |
| Total Debt | $17M | $10M | · | |
| Paid-in Capital | $353M | $290M | $5M | |
| Retained Earnings | $-202M | $-138M | $-77M | |
| AOCI | $22.0K | $-101.0K | $-79.0K | |
| Stockholders' Equity | $151M | $151M | $-72M | |
| Liabilities + Equity | $185M | $178M | $87M | |
| Shares Outstanding | 31,924,000 | 26,987,000 | 3,832,000 |
Nakit Akışı 10
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | · | $502.0K | $373.0K | |
| Stock-based Comp | $8M | $8M | $3M | |
| Other Non-cash | · | $6M | · | |
| Operating Cash Flow | $-52M | $-47M | $-33M | |
| CapEx | $24.0K | $2M | $470.0K | |
| Investing Cash Flow | $-24.0K | $-2M | $-470.0K | |
| Net Debt Issued | $-10M | · | · | |
| Financing Cash Flow | $60M | $136M | $68M | |
| Net Change in Cash | $8M | $86M | $34M | |
| Free Cash Flow | $-52M | $-49M | · |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -34.9% | -46.5% | · | |
| ROE | -46.1% | -38.8% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.7 | 16.9 | · | |
| Quick Ratio | 15.6 | 16.8 | · | |
| Debt / Equity | 0.1 | 0.1 | · | |
| LT Debt / Equity | 0.1 | 0.1 | · |
Değerleme (TTM) 11
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-63M | $-61M | $-36M | |
| Market Cap | $568M | $114M | · | |
| Enterprise Value | $409M | $-44M | · | |
| P/E | -8.1 | -1.7 | · | |
| P/B | 3.8 | 0.8 | · | |
| P / Tangible Book | 3.8 | 0.8 | · | |
| P / Cash Flow | -11.0 | -2.4 | · | |
| P / FCF | -11.0 | -2.3 | · | |
| EV / EBITDA | -6.2 | 0.6 | · | |
| EV / FCF | -7.9 | 0.9 | · | |
| Earnings Yield | -12.3% | -59.1% | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $12M | $11M | $13M | $10M | $11M | $13M | $13M | $10M | $10M | $8M | $7M | $6M | |
| SG&A Expense | $5M | $4M | $6M | $6M | $6M | $6M | $5M | $4M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $17M | $15M | $19M | $16M | $17M | $19M | $18M | $14M | $12M | $10M | $9M | $7M | |
| Operating Income | $-17M | $-15M | $-19M | $-16M | $-17M | $-19M | $-18M | $-14M | $-12M | $-10M | $-9M | $-7M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $738.0K | $714.0K | $667.0K | $230.0K | |
| Other Non-op | $873.0K | $770.0K | $976.0K | $507.0K | $2M | $2M | $2M | $969.0K | $548.0K | $577.0K | $462.0K | $-83.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-16M | $-14M | $-18M | $-15M | $-15M | $-17M | $-16M | $-13M | $-11M | $-9M | $-9M | $-7M | |
| EPS (Basic) | $-0.46 | $-0.52 | $-0.65 | $-0.56 | $-0.52 | $-0.62 | $-0.60 | $-0.76 | $-2.99 | $-2.44 | $-2.33 | $-1.97 | |
| EPS (Diluted) | $-0.46 | $-0.52 | $-0.65 | $-0.56 | $-0.52 | $-0.62 | $-0.60 | $-0.76 | $-2.99 | $-2.44 | $-2.33 | $-1.97 | |
| Shares (Basic) | -52,373,000 | 27,104,000 | 27,072,000 | 27,049,000 | -46,870,000 | 26,959,000 | 26,913,000 | 17,600,000 | -7,418,000 | 3,742,000 | 3,716,000 | 3,691,000 | |
| Shares (Diluted) | -52,373,000 | 27,104,000 | 27,072,000 | 27,049,000 | -46,870,000 | 26,959,000 | 26,913,000 | 17,600,000 | -7,418,000 | 3,742,000 | 3,716,000 | 3,691,000 | |
| EBITDA | · | $-15M | $-19M | $-16M | · | $-19M | $-18M | $-14M | · | · | · | · |
Bilanço 20
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $176M | $138M | $148M | $161M | $168M | $182M | $193M | $206M | $83M | · | · | · | |
| Prepaid Expense | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $3M | · | · | · | |
| Other Current Assets | · | · | · | $23.0K | · | $277.0K | $148.0K | $150.0K | $112.0K | · | · | · | |
| Current Assets | $178M | $139M | $150M | $164M | $169M | $184M | $195M | $208M | $85M | · | · | · | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | $1M | · | · | · | |
| Accum. Depreciation | $2M | $1M | $1M | $1M | $1M | $909.0K | $791.0K | $781.0K | $684.0K | · | · | · | |
| Total Assets | $185M | $147M | $158M | $172M | $178M | $192M | $197M | $210M | $87M | · | · | · | |
| Accounts Payable | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $1M | · | · | · | |
| Accrued Liabilities | $9M | $7M | $6M | $6M | $8M | $8M | $6M | $4M | $5M | · | · | · | |
| Current Liabilities | $11M | $9M | $8M | $7M | $10M | $14M | $10M | $8M | $6M | · | · | · | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $5M | · | · | $0 | · | · | · | |
| Total Liabilities | $34M | $35M | $34M | $33M | $26M | $27M | $18M | $17M | $17M | · | · | · | |
| Long-term Debt | $17M | · | · | · | $10M | $10M | $10M | $10M | · | · | · | · | |
| Total Debt | · | $20M | $20M | $20M | · | $10M | $10M | $10M | · | · | · | · | |
| Paid-in Capital | $353M | $297M | $295M | $293M | $290M | $288M | $286M | $284M | $5M | · | · | · | |
| Retained Earnings | $-202M | $-185M | $-171M | $-154M | $-138M | $-123M | $-106M | $-90M | $-77M | · | · | · | |
| AOCI | $22.0K | $14.0K | $31.0K | $14.0K | $-101.0K | $-95.0K | $-89.0K | $-84.0K | $-79.0K | · | · | · | |
| Stockholders' Equity | $151M | $112M | $123M | $139M | $151M | $165M | $180M | $193M | $-72M | · | · | · | |
| Liabilities + Equity | $185M | $147M | $158M | $172M | $178M | $192M | $197M | $210M | $87M | · | · | · | |
| Shares Outstanding | 31,924,000 | 27,168,000 | 27,072,000 | 27,072,000 | 26,987,000 | 26,968,000 | 26,951,000 | 26,884,000 | 3,832,000 | · | · | · |
Nakit Akışı 11
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $100.0K | $171.0K | · | $200.0K | $100.0K | $97.0K | $87.0K | $100.0K | $100.0K | $86.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $606.0K | $541.0K | $1M | $484.0K | |
| Other Non-cash | · | · | · | $-4M | · | · | · | $158.0K | · | · | · | · | |
| Operating Cash Flow | $-12M | $-10M | $-14M | $-17M | $-13M | $-12M | $-12M | $-11M | $-12M | $-8M | $-7M | $-8M | |
| CapEx | $0 | $0 | $0 | $24.0K | $506.0K | $1M | $340.0K | $224.0K | $352.0K | $43.0K | $54.0K | $21.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $-24.0K | $-506.0K | $-1M | $-340.0K | $-224.0K | $-352.0K | $-43.0K | $-54.0K | $-21.0K | |
| Debt Issued | · | · | · | $20M | · | · | · | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $9M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50M | $153.0K | $613.0K | $9M | $49.0K | $1M | $-234.0K | $135M | $43M | $49.0K | $-51.0K | $25M | |
| Net Change in Cash | $39M | $-10M | $-13M | $-7M | $-13M | $-11M | $-12M | $123M | $31M | $-8M | $-7M | $17M | |
| Free Cash Flow | · | · | · | $-17M | · | · | · | $-11M | · | · | · | · |
Kârlılık 2
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -8.4% | -10.0% | -8.0% | · | -17.5% | -16.2% | -12.8% | · | · | · | · | |
| ROE | · | -10.2% | -11.7% | -9.1% | · | -20.3% | -17.8% | -13.9% | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 15.4 | 18.4 | 22.5 | · | 13.1 | 19.9 | 26.0 | · | · | · | · | |
| Quick Ratio | · | 15.2 | 18.2 | 22.2 | · | 13.0 | 19.6 | 25.7 | · | · | · | · | |
| Debt / Equity | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| LT Debt / Equity | · | 0.2 | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-64M | $-66M | $-61M | · | $-55M | $-47M | $-39M | · | · | · | · | |
| Market Cap | · | $109M | $60M | $58M | · | $309M | $288M | $413M | · | · | · | · | |
| Enterprise Value | · | $-8M | $-68M | $-82M | · | $137M | $105M | $217M | · | · | · | · | |
| P/E | · | -1.7 | -0.9 | -0.9 | · | -2.6 | -1.7 | -2.0 | · | · | · | · | |
| P/B | · | 1.0 | 0.5 | 0.4 | · | 1.9 | 1.6 | 2.1 | · | · | · | · | |
| P / Tangible Book | · | 1.0 | 0.5 | 0.4 | · | 1.9 | 1.6 | 2.1 | · | · | · | · | |
| P / Cash Flow | · | · | · | -3.5 | · | · | · | -37.6 | · | · | · | · | |
| P / FCF | · | · | · | -3.5 | · | · | · | -36.8 | · | · | · | · | |
| EV / EBITDA | · | 0.6 | 3.7 | 5.3 | · | -7.3 | -5.8 | -15.2 | · | · | · | · | |
| EV / FCF | · | · | · | 5.0 | · | · | · | -19.3 | · | · | · | · | |
| Earnings Yield | · | -58.5% | -110.5% | -117.6% | · | -38.6% | -57.3% | -48.9% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Net Gelir | $-63M | $-61M | $-36M |
| Seyreltilmiş Hisse Başı Kâr | $-2.19 | $-2.50 | $-9.73 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Borç / Öz Sermaye | 0.1 | 0.1 | — |
| Cari Oran | 15.7 | 16.9 | — |
| Cari Oran | 15.6 | 16.8 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Serbest Nakit Akışı | $-52M | $-49M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.